Evidence map›Paper›PMID 42069986›Full record

ArticleMolecular biotechnology2026

A CHO-Derived Matrix Attachment Region Enhances Transgene Dosage, SATB1 Recruitment, and Monoclonal Antibody Expression in a Dual-Promoter Vector System.

Sarmishta Majumdar, Rupashree Salvi, Prajakta Dandekar, Ratnesh Jain

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarmishta MajumdarDepartment of Biological Sciences and Biotechnology, Institute of Chemical Technology, NP Marg, Matunga, Mumbai, Maharashtra, 400019, India.ORCID http://orcid.org/0009-0004-4439-0634
Rupashree SalviDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, NP Marg, Matunga, Mumbai, Maharashtra, 400019, India.ORCID http://orcid.org/0000-0002-3959-8754
Prajakta DandekarDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, NP Marg, Matunga, Mumbai, Maharashtra, 400019, India. pd.jain@ictmumbai.edu.in.
Ratnesh JainDepartment of Biological Sciences and Biotechnology, Institute of Chemical Technology, NP Marg, Matunga, Mumbai, Maharashtra, 400019, India. rd.jain@ictmumbai.edu.in.ORCID http://orcid.org/0000-0001-6887-9400

Funding

Department of Biotechnology, India BT/INF/22/SP47618/2023University Grant Commission UGC-22-GE-MAH-F-SJSGC-10886
6 · The paper itself

Abstract

The production of monoclonal antibodies (mAbs) in Chinese hamster ovary (CHO) cells is often affected by position-effect variegation and the gradual loss of transgene expression over time. Hence, we have designed a dual-promoter IgG expression vector and compared versions that either contained or lacked a CHO-derived matrix-attachment region (MAR). Stable CHO-S pools, cultured in serum-free conditions, revealed that the MAR-containing construct produced higher and more consistent antibody levels across ten passages, as confirmed by Western blot and Protein A Octet analysis. Product-quality analysis by size-exclusion chromatography and reducing SDS-PAGE confirmed formation of properly assembled, mainly monomeric antibodies in both cases. Quantitative PCR indicated greater transgene copy numbers in MAR pools (+ 48% for the light chain and + 71% for the heavy chain), and RT-qPCR showed roughly fourfold higher transcript levels for both chains relative to controls. Bioinformatic analysis revealed several SATB1 binding motifs within the MAR sequence, and ChIP-qPCR demonstrated SATB1 association with the MAR-linked transgene locus. Overall, the data suggested that a CHO-native MAR could enhance transgene dosage and transcriptional activity, while preserving product integrity, possibly through SATB1-mediated chromatin organization. Ongoing work includes chromatin-mark profiling and process-level productivity measurements to better define the impact of MAR-based vector design on biomanufacturing performance.

Indexed as

Antibodies, MonoclonalGene DosageGenetic VectorsMatrix Attachment Region Binding ProteinsMatrix Attachment RegionsPromoter Regions, GeneticTransgenesAnimalsCHO CellsCricetinaeCricetulusHumansImmunoglobulin GAntibodies, MonoclonalImmunoglobulin GMatrix Attachment Region Binding ProteinsSATB1 protein, humanCHO cellsMammalian expression systemMatrix attachment region (MAR)Monoclonal antibody expressionRecombinant protein production

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.